← Insider buys
AGIO

Agios Pharmaceuticals, Inc. · Healthcare

Chief Commercial Officer Tsveta Milanova sold $78K of Agios Pharmaceuticals, Inc.

Sold$77,601
$27.02Price
2,872Shares
−8%Stake

What AGIO did after the filing

Filed Jan 7Copier in Jan 8
The stock from Thu, Jan 8 open, $28.24
+6.9%
S&P 500, same days
−0.9%

Measured over 30 trading days, to the Feb 23 close.

Traded Mon, Jan 5. Filed Wed, Jan 7, 4:23 PM ET, after the close. Returns use the Jan 8 open and the Feb 23 close. Not investment advice.